Aequus Pharmaceuticals Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 18

Employees

  • Stock Symbol
  • AQS

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.02
  • (As of Monday Closing)

Aequus Pharmaceuticals General Information

Description

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Stock Exchange
TSX
Corporate Office
  • 2820 - 200 Granville Street
  • Vancouver, British Columbia V6C 1S4
  • Canada
+1 (604) 000-0000

Aequus Pharmaceuticals Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aequus Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.02 $0.01 $2.43M 133M 241K -$0.01

Aequus Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 3,904 5,430 4,936 11,388
Revenue 159 189 1,059 2,164
EBITDA (1,914) (1,989) (2,219) (988)
Net Income (2,136) (2,195) (2,464) (1,443)
Total Assets 808 819 1,246 3,410
Total Debt 4,198 3,817 2,050 1,710
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aequus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aequus Pharmaceuticals‘s full profile, request access.

Request a free trial

Aequus Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Com
Pharmaceuticals
Vancouver, Canada
18 As of 2022
000.00
000000000 000.00

000000

ipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
000000000000000
Dublin, Ireland
0000 As of 0000
00.00
000000000 00 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aequus Pharmaceuticals Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Perrigo Company Corporation Dublin, Ireland 0000 00.00 000000000 00 00.00
You’re viewing 1 of 1 competitors. Get the full list »

Aequus Pharmaceuticals Patents

Aequus Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3337480-A1 Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride Inactive 17-Aug-2015 00000000000
EP-3337480-A4 Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride Inactive 17-Aug-2015 00000000000 0
US-20180250281-A1 Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride Inactive 17-Aug-2015 00000000000
CA-2995431-A1 Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride Inactive 17-Aug-2015 00000000000
JP-5966228-B2 Aripiprazole composition Active 28-Oct-2010 A61K9/08
To view Aequus Pharmaceuticals’s complete patent history, request access »

Aequus Pharmaceuticals Executive Team (7)

Name Title Board Seat Contact Info
Anne Stevens Director
James Meikle Director of Business Development & Corporate Strategy
Grant Larsen Executive
Douglas Janzen President, Chief Executive Officer & Chairman
Ann Fehr Chief Financial Officer & Corporate Secretary
You’re viewing 5 of 7 executive team members. Get the full list »

Aequus Pharmaceuticals Board Members (5)

Name Representing Role Since
Christopher Clark Aequus Pharmaceuticals Board Member 000 0000
Douglas Janzen Self President, Chief Executive Officer & Chairman 000 0000
Marc Lustig Self Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Aequus Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aequus Pharmaceuticals Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Aequus Pharmaceuticals / Medicom) 22-Sep-2020 00000 0000 Distributors/Wholesale
Cannabis-based Therapies (CannaRoyalty / Aequus Pharmaceuticals) 11-Jan-2018 00000 0000 Biotechnology 0000000 0
TeOra Health 28-Jul-2015 Merger/Acquisition 00.000 Other Commercial Services 0000000 0
To view Aequus Pharmaceuticals’s complete investments and acquisitions history, request access »

Aequus Pharmaceuticals FAQs

  • When was Aequus Pharmaceuticals founded?

    Aequus Pharmaceuticals was founded in 2013.

  • Who is the CEO of Aequus Pharmaceuticals?

    Douglas Janzen is the CEO of Aequus Pharmaceuticals.

  • Where is Aequus Pharmaceuticals headquartered?

    Aequus Pharmaceuticals is headquartered in Vancouver, Canada.

  • What is the size of Aequus Pharmaceuticals?

    Aequus Pharmaceuticals has 18 total employees.

  • What industry is Aequus Pharmaceuticals in?

    Aequus Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Aequus Pharmaceuticals a private or public company?

    Aequus Pharmaceuticals is a Public company.

  • What is Aequus Pharmaceuticals’s stock symbol?

    The ticker symbol for Aequus Pharmaceuticals is AQS.

  • What is the current stock price of Aequus Pharmaceuticals?

    As of 27-May-2024 the stock price of Aequus Pharmaceuticals is $0.02.

  • What is the current market cap of Aequus Pharmaceuticals?

    The current market capitalization of Aequus Pharmaceuticals is $2.43M.

  • What is Aequus Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for Aequus Pharmaceuticals is $159K.

  • Who are Aequus Pharmaceuticals’s competitors?

    Perrigo Company is a competitor of Aequus Pharmaceuticals.

  • What is Aequus Pharmaceuticals’s annual earnings per share (EPS)?

    Aequus Pharmaceuticals’s EPS for 12 months was -$0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »